Recommended
October 01, 2024
Global Myopia Rates in Children and Teens Expected to Surpass 740 Million by 2050
A new analysis published in the British Journal of Ophthalmology reveals that nearly one in three children and teens worldwide is expected to be affected by myopia by 2050, translating to over 740 million cases.
Breaking News
Adverse Effects Identified Following Faricimab Treatment for Eye Conditions
Oct 15, 2024
Researchers from the University Hospital Zurich have reported cases of sterile intraocular inflammation, including severe retinal vasculitis, associated with faricimab injections.
Eye Drop Company Faces FDA Scrutiny Again Over Unapproved Products
Sep 19, 2024
The FDA has issued a warning letter to the Regenerative Processing Plant, manufacturer of Regener-Eyes Pro and Lite eye drops, for marketing unapproved products claiming to treat dry eyes.
Maestro®: The Sinusoidal IOL
Sep 18, 2024
VSY Biotechnology introduced the Maestro® Sinusoidal IOL at ESCRS 2024, featuring SVT. This innovative trifocal lens enhances visual acuity, contrast sensitivity, and light transmission, offering a cutting-edge solution for presbyopia management.
.jpg)
Industry News
Opthea Announces Leadership Changes as it Prepares for Phase 3 Data on Sozinibercept
Sep 06, 2924
Opthea has announced key leadership appointments to strengthen its commercial and clinical capabilities as it prepares for the 2025 topline data readout of Phase 3 trials for sozinibercept, its lead candidate for wet AMD.
BlueRock Therapeutics Receives FDA Clearance for OpCT-001 IND Application
Sep 05, 2924
BlueRock Therapeutics, a subsidiary of Bayer, announced that the FDA has cleared its investigational new drug (IND) application for OpCT-001, a stem cell therapy designed to treat primary photoreceptor diseases.
Ophthalmic Drug Delivery Summit to Convene in San Francisco
Oct 15, 2024
In January, over 60 world-renowned experts in ophthalmic drug delivery will gather in San Francisco for the 3rd annual Ophthalmic Drug Delivery Summit.
Ophthalmic Research News
Color Vision Deficiency May Affect Diagnosis of Choroidal Conditions
Sep 24, 2924
Color vision deficiency (CVD) can affect an ophthalmologist’s ability to differentiate between choroidal melanoma and choroidal nevus, potentially leading to misdiagnoses.
The Relationship Between Blood Pressure and Intraocular Pressure in Glaucoma Risk
Oct 01, 2024
Evidence suggests that ocular perfusion pressure is a strong risk factor for glaucoma. Ocular perfusion pressure is the relationship between the eye pressure and the blood pressure.
Nicotine's Potential in Myopia Control: Animal Research Findings
Sep 27, 2024
Researchers led by Dr. Kate Thomson from the University of Canberra have found that nicotine, when administered either as an intravitreal injection or topical eye drop, significantly inhibited the development of FDM and LIM in chicks.
Ophthalmic Blog
Global Myopia Rates in Children and Teens Expected to Surpass 740 Million by 2050
Oct 01, 2024
A new analysis published in the British Journal of Ophthalmology reveals that nearly one in three children and teens worldwide is expected to be affected by myopia by 2050, translating to over 740 million cases.
Lamprey's Eye Disease: Separating Fact from Fiction
Sep 30, 2024
Lamprey Eye Disease, also known as "Lamprey Disease," is a hoax that has been circulating on the internet for several years. The hoax claims that a parasitic fish known as the lamprey is responsible for a disease that can cause blindness in humans.
ChatGPT-4.0 Demonstrates Promise in Addressing Retinal Disease Queries
Aug 27, 2024
A recent study highlights the potential of ChatGPT-4.0 in accurately answering questions related to retinal diseases, covering diagnostic criteria, treatment guidelines, and management strategies.
Ophthalmology Breaking News Subscribe